Contact Us / Sitemap / Directions / Patients and Visitors / Career Opportunities / Medical Staff
pay your hospital bill pay your doctor's bill paying for your care
Winthrop University Hospital

Future Revascularization Evaluation in patients with Diabetes mellitus


This is a multicenter, two-arm, open label prospective randomized trial. The objective of this trial is to evaluate whether percutaneous coronary intervention (PCI) with drug-eluting stenting (DES) is more or less effective than the existing standard of care, coronary artery bypass surgery (CABG).


Winthrop-University Hospital - Division of Cardiology is one of the participating site to enroll subjects with diabetes mellitus (Type 1 or Type 2) with angiographically confirmed multivessel coronary artery disease (CAD) and morphology amenable to either PCI or CABG, with indication for revascuralization based upon symptoms or angina and/or objective evidence of myocardial ischemia. Eligible subjects are randomized to receive either CABG or multivessel stenting using drug-eluting stents, and followed at 30 days, 1 year and then annually for up to 6.75 years.


Eligibility Criteria: - Age 18 years or older - Diabetes Mellitus (Type 1 or Type 2) undergoing treatment - Angiographically confirmed multivessel CAD lesions in at least two major coronary arteries

Principal Investigator

Srihari Naidu, MD


Division of Cardiology


Other Contact

For more information please call Research Coordinator at 516-663-8692.
Contact Us / Sitemap / Directions / Career Opportunities / Financial Assistance / Policies
Winthrop-University Hospital
259 First Street | Mineola NY 11501 | 516-663-0333

This site provides information as a resource. It is not a substitute for professional medical advice.
Always consult a physician or healthcare provider for treatment and guidance toward good health.
Copyright © 2015 Winthrop-University Hospital. All rights reserved.
Web site by: Long Island Web Design